2026 Series B Funding Boom: Record $68M Averages Fuel AI, Biotech, Robotics, and Defense Startup Surge
Venture capitalists are fueling a robust recovery in Series B funding during 2026, with average round sizes hitting a record-high $68 million.
This uptick follows a 2023 nadir, showcasing a refreshingly diversified pipeline beyond pure AI hype into biotech, robotics, security, and health.
Sector Breakdown Reveals Broad Appeal
Healthcare and biotech captured over 25% of Series B investments in the past six months.
AI-related ventures across industries claimed roughly half of the funding pie.
Robotics and hardware firms secured about 15%, signaling a hardware renaissance.
Software-centric companies dominated the majority of deals, affirming their scalability edge.
Mega-Rounds Spotlight Key Players
Reflection AI raised a staggering $2 billion led by Nvidia for open foundation models.
In October, Kailera Therapeutics hauled in $600 million targeting obesity innovations.
Physical Intelligence followed in November with $600 million from Google's CapitalG for AI robotics.
Trends, History, and Future Outlook
Smaller rounds under $10 million plummeted from 150 yearly pre-2023 to 44 last year, favoring larger consolidations.
This evolution underscores investors betting on proven tech edges and traction at Series B, mitigating risks across vital sectors.
Forward, this diversified momentum promises accelerated breakthroughs with profound impacts on defense, health, and global innovation.
